top border
top border
Featured Programs

Metastatic Melanoma: The New Millennium
Keith Flaherty, MD, moderates this discussion with Rene Gonzalez, MD, Jason Luke, MD, FACP, and Jeffrey Weber, MD, PhD. The panel of experts in melanoma research and treatment talk about the most recent advances in the field, and provide perspective on how to apply the newest data to individualize treatment strategies.

View Now

Therapeutic Strategies in Metastatic Colorectal Cancer


F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, and investigator at the Ludwig Center at Harvard, discusses the results of a 5-year follow-up analysis of survival outcomes of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

View Now

Featured Video

Hepatocellular Carcinoma (HCC):
Can We Improve Patient Survival?

Hepatocellular Carcinoma (HCC): Can We Improve Patient Survival?
Richard Finn, MD, Laura M. Kulik, MD, and Matthew S. Johnson, MD, FSIR, discuss the evolving systemic treatment paradigm for patients with advanced hepatocellular carcinoma. View now

Gina Columbus

Gina Columbus reports on the latest news in oncology in this week's edition of OncLive News Network.

Publication Bottom Border
Border Publication